Court limits mail-order abortion pill access

A US appeals court has ruled to restrict mail-order access to mifepristone, the drug used in medication abortions, which is currently the most common method for the procedure in the country. The decision requires in-person distribution at clinics, effectively curbing the availability of the drug via mail. This ruling aligns with earlier actions by the Fifth Circuit Court of Appeals, which had temporarily blocked mail-order abortions using mifepristone. The move is expected to significantly impact access to abortion services, particularly in states with limited clinic availability.